Back
PTC Therapeutics Vs. Vertex Pharmaceuticals Industry Stock Comparison
Sell
37
PTCT
PTC Therapeutics
Last Price:
43.22
Seasonality Move:
23.53%
Sell
47
VRTX
Vertex Pharmaceuticals
Last Price:
450.53
Seasonality Move:
11.1%
Sell
37
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $43.23. The Score for PTCT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $450.97. The Score for VRTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $43.23
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing slight selling pressure.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $450.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing selling pressure, which indicates risk of future bearish movement.
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.78 | Buy |
| Relative Strength Index (14 RSI): | 58.19 | Buy |
| Chaikin Money Flow: | -153314 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.76 - 43.44) | Buy |
| Bollinger Bands (100): | (32.22 - 39.98) | Buy |
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.14 | Sell |
| Relative Strength Index (14 RSI): | 38.12 | Sell |
| Chaikin Money Flow: | -690526 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (459.98 - 494.52) | Sell |
| Bollinger Bands (100): | (464.62 - 492.24) | Sell |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.54 | Buy |
| 20-day SMA: | 41.88 | Buy |
| 50-day SMA: | 39.24 | Buy |
| 200-day SMA: | 33.55 | Buy |
| 8-day EMA: | 42 | Buy |
| 20-day EMA: | 41.51 | Buy |
| 50-day EMA: | 39.53 | Buy |
| 200-day EMA: | 35.15 | Buy |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 463.98 | Sell |
| 20-day SMA: | 477.93 | Sell |
| 50-day SMA: | 473.88 | Sell |
| 200-day SMA: | 453.97 | Sell |
| 8-day EMA: | 461.92 | Sell |
| 20-day EMA: | 472.05 | Sell |
| 50-day EMA: | 474.74 | Sell |
| 200-day EMA: | 452.65 | Sell |
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.55 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.53 per share, and an increase next year of $18.25 per share.
PTC Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vertex Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||